F. Verrier et al., Immunisation with whole purified human immunodeficiency virus type 1 particles elicits enhancing antibodies in rhesus macaques, B ACA N MED, 184(1), 2000, pp. 67-87
Six Rhesus macaques were hyperimmunized with either live infectious human i
mmunodeficiency virus type 1 (HIV-1) or with beta-propiolactone - or formal
in - inactivated HIV-1. The virus used was HIV-1 BX08, a primary virus isol
ate grown in human PBMC. Instead of eliciting virus-neutralizing antibodies
, this regimen induced antibodies that enhanced HIV-1 infectivity for PBMC
by 10 to 90 fold. Enhancement was also seen in a cell-to-cell fusion assay
using a Semliki Forest virus replicon to express BX08 gp160 in CD4(+), and
CCR5(+) HeLa cell cultures. These observations raise the concern that whole
virus particles-based HIV-1 vaccines might elicit enhancing antibodies tha
t could play a facilitating role in the transmission and/or evolution of th
e disease.